Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 206.36

+1.4%

Nov 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: WTDEC who wrote (21919)	6/6/1998 8:21:00 AM
From: Henry Niman	Read Replies (1) of 32384

W, An interferon agonist program has been listed by LGND for several years (see home.att.net ), but I had thought that the transcription factors (back end of the pathway)were being targeted, not the interferon receptor (front end of the pathway). Are you referring to the former or latter? If they were talking about a mimic in the same sense as the G-CSF mimic, then it would be the front end and would given them an even stronger patent position (as well as leadership in a newly defined field).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next